p53 肿瘤抑制因子是响应多种细胞损伤而导致生长停滞、衰老和凋亡的主要介质。p53 是一种短寿命蛋白质,在正常细胞中维持在较低水平,通常无法检测到。在压力条件下,p53 蛋白在细胞中积累,以四聚体形式与 p53 反应元件结合并诱导各种基因的转录。
MDM-2 由 p53 转录激活,而 MDM-2 反过来以多种方式抑制 p53 活性。MDM-2 与 p53 转录激活域结合,从而抑制 p53 介导的转录激活。MDM-2 还包含类似于各种病毒蛋白的核输出信号的信号序列,在与 p53 结合后,它会诱导其核输出。由于 p53 是一种转录因子,它需要位于细胞核中才能接触 DNA; MDM-2 将其转运至细胞质可防止这种情况发生。最后,MDM-2 是一种泛素连接酶,因此能够靶向 p53 并由蛋白酶体降解。在许多肿瘤中,p53 因负调节因子 MDM2 和 MDM4 的过度表达或 MDM2 抑制剂 ARF 的活性丧失而失活。这些肿瘤中的该通路可以通过抑制 MDM2 和/或 MDM4 与 p53 相互作用的小分子重新激活。此类分子目前正在临床试验中。
The p53 tumor suppressor is a principal mediator of growth arrest, senescence, and apoptosis in response to a broad array of cellular damage. p53 is a short-lived protein that is maintained at low, often undetectable, levels in normal cells. Under stress conditions, the p53 protein accumulates in the cell, binds in its tetrameric form to p53-response elements and induces the transcription of various genes.
MDM-2 is transcriptionally activated by p53 and MDM-2, in turn, inhibits p53 activity in several ways. MDM-2 binds to the p53 transactivation domain and thereby inhibits p53-mediated transactivation. MDM-2 also contains a signal sequence that is similar to the nuclear export signal of various viral proteins and, after binding to p53, it induces its nuclear export. As p53 is a transcription factor, it needs to be in the nucleus to be able to access the DNA; its transport to the cytoplasm by MDM-2 prevents this. Finally, MDM-2 is a ubiquitin ligase, so is able to target p53 for degradation by the proteasome.
In many tumors p53 is inactivated by the overexpression of the negative regulators MDM2 and MDM4 or by the loss of activity of the MDM2 inhibitor ARF. The pathway can be reactivated in these tumors by small molecules that inhibit the interaction of MDM2 and/or MDM4 with p53. Such molecules are now in clinical trials.
(3S,5S,6R)-Navtemadlin 是 Navtemadlin (MS-Y29185) 的异构体,可作为实验中的对照化合物,而 Navtemadlin (AMG 232) 是一种有效、选择性、可口服的 p53-MDM2 相互作用抑制剂,IC50 值为 0.6 nM,与 MDM2 结合的 Kd 为 0.045 nM。
(S,R,S)-MI-1061 是 MI-1061(MS-G01490)的异构体,可用于合成抗体药物偶联物(Antibody-Drug Conjugates, ADCs);MI-1061 是一种有效的、口服可生物利用的、化学稳定的 MDM2(MDM2-p53 互作)抑制剂(IC50=4.4 nM;Ki=0.16 nM),可激活小鼠 SJSA-1 异种移植瘤组织中的 p53 并诱导凋亡,具有抗肿瘤活性。
Idasanutlin enantiomer 是 Idasanutlin (MS-Q63464) 的异构体,可作为实验中的对照化合物,而 Idasanutlin (RG7388) 是一种有效且选择性的 MDM2 拮抗剂,能够抑制 p53-MDM2 的结合,IC50 值为 6 nM。
ReACp53 scrambled peptide TFA 是 ReACp53 (MS-T62339) 的阴性对照,可用于卵巢癌的研究。
Siremadlin R Enantiomer (NVP-HDM201 R Enantiomer) 是 Siremadlin 的 R 型对映体,而 Siremadlin 是一种高效、选择性的 MDM-2/p53 抑制剂。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号